2023: A Year Of Market Surprises And The Path Forward For Investors In 2024
From Barchart: Experts are advising investors on how to navigate the unexpected market events of 2023 to craft successful investment
Category: Markets
Guru Fundamental Report for GS
From Nasdaq: Validea’s guru fundamental report for GOLDMAN SACHS GROUP INC (GS) rates it highest in the Shareholder Yield Investor
Singular Genomics Reports Instrument Shipments and
From GlobeNewswire: Singular Genomics Systems, Inc. announced preliminary Q4 2023 revenue of approximately $1.0 million and the shipment of eight
Guru Fundamental Report for NEE
From Nasdaq: NEE has achieved the highest rating from Validea’s Multi-Factor Investor model. NEXTERA ENERGY INC (NEE) currently rates highest
These mutual fund and ETF investing tips can freshen your portfolio
From Dow Jones & Company: 1. ETF’s strategy has been working, with low price-to-earnings valuation and high growth rates for
Amicus Therapeutics Reports Preliminary 2023 Revenue and
From GlobeNewswire: Amicus Therapeutics, a global biotechnology company, anticipates a 11-16% revenue growth in 2024 following a successful 2023. Total
Earnings, Boeing News and Other Can’t Miss Items This Week
From Barchart: A Boeing (BA) plane experienced a mid-air window blow out, raising concerns about the company’s safety standards. Investors
Guru Fundamental Report for INTU – Martin Zweig
From Nasdaq, Inc.: INTUIT INC. (INTU) rates highest in Validea’s guru fundamental report using the Growth Investor model, with a
Fed’s Logan backs first slowing, then gradually ending, balance-sheet runoff
From Dow Jones & Company: Dallas Fed President Lorie Logan suggested slowing the pace of the Federal Reserve’s balance-sheet reduction
QIAGEN announces plans to return approximately $300 million
From GlobeNewswire: QIAGEN N.V. is returning up to approximately $300 million to shareholders through a synthetic share repurchase combining direct
Guru Fundamental Report for ORCL
From “Nasdaq, Inc.”: ORACLE CORP (ORCL) has received the highest rating from Validea’s Multi-Factor Investor model based on the strategy
QIAGEN gibt Pläne zur Rückzahlung von rund $300 Mio. an
From GlobeNewswire: QIAGEN N.V. plans to offer a capital repayment through a synthetic share buyback, potentially up to $300 million,
Should You Buy Polkadot (DOT) While It’s Below $10?
From Nasdaq, Inc.: The Polkadot (CRYPTO: DOT) cryptocurrency saw a short-lived spike to nearly $10 per token on Christmas Day
Saudis cut crude prices to all regions amid oil-price weakness
From Dow Jones & Company: Saudi Aramco announces it’s cutting crude oil prices for all regions, including Asia, in response
Exagen Inc. Announces Select Preliminary Full-Year 2023
From GlobeNewswire: Exagen Inc. announces preliminary unaudited financial results for 2023, including a record volume of AVISE® CTD testing units
3 Reasons to Buy Toast Stock Like There’s No Tomorrow
From Nasdaq: The stock price of Toast (NYSE: TOST) has declined over 50% since its IPO in September 2021, significantly
Why stock-market investors will remain at mercy of shifting rate-cut expectations
From Dow Jones & Company: Stock investors are off to a rocky start in 2024, as expectations around Federal Reserve
Strong Q4 sales lift full year
From GlobeNewswire: Preliminary and unaudited results for 2023 show a double-digit organic growth of +12% in Q4. Key markets in
Is Symbotic Stock a Buy?
From Nasdaq, Inc.: Symbotic stock (NASDAQ: SYM) had exceptional growth last year, outperforming Nvidia. The company uses proprietary automation systems
Caribou Biosciences Appoints Tim Kelly as Chief Technology
From GlobeNewswire: Tim Kelly has been appointed as the chief technology officer at Caribou Biosciences, Inc. He brings over 25
Brokerage Firms Are Pitching Separately Managed Accounts. Here’s What to Know.
From Wall Street Journal: Investors are being drawn to personalized portfolios for their tax benefits and potential for high returns.
Why Photronics Rocketed 48.5% Higher in December
From Nasdaq: Photronics’ stock, NASDAQ: PLAB, surged 48.5% in December after the company reported impressive fourth fiscal quarter earnings. The
Gentex Announces eSight Acquisition Set to Showcase
From GlobeNewswire: Gentex Corporation (NASDAQ: GNTX) has just announced they have acquired eSight, a leading provider of vision enhancement technologies.
Disney Stock 2025 Forecast: Can a ‘Golden Cross’ Carry DIS Higher?
From Barchart: Despite underperforming the markets in the last decade, the 2025 forecast for Disney stock (DIS) is positive. Investors
The Best Stock Funds of 2023
From Dow Jones & Company: Despite losses in 2022, mutual-fund managers saw a rebound in large and megacap stocks, especially